Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Zila, Inc (ZILA) Receives FDA Clearance

Zila, Inc. (NASDAQ: ZILA) announced this morning that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market ViziLite Eyewear. Worn by a health care professional, ViziLite Eyewear helps eliminate ambient light while performing an oral exam under chemiluminescence when a darkened room is not available. The eyewear also allows only the transmission of light necessary for a ViziLite examination while blocking interfering ambient light.

“ViziLite Eyewear helps health care professionals administer ViziLite(R) Plus, our oral cancer screening product, in less than ideal lighting environments,” said David Bethune, chairman and chief executive officer of Zila. “ViziLite Eyewear complements our product offering and will be marketed by the company’s direct sales force.”

Zila, Inc is an oral diagnostic company focused on the prevention, detection and treatment of oral cancer and periodontal disease. The company’s flagship product, ViziLite® Plus is used in the detection of oral abnormalities that could lead to cancer. Zila also designs, manufactures and markets a variety of products sold exclusively for both in-office and home-care use. Rota-dent(R) Professional Powered Brush and the Pro-Select(R) Platinum ultrasonic scaler are some of the company’s other products sold.

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *